Real World Treatment Outcomes in Chinese Patients with RET-Rearranged Lung Cancer

被引：0
|
作者：
Yang, L. [1 ]
Liu, Z. [2 ]
Qiu, W. [3 ]
Yang, G. [4 ]
Xu, H. [5 ]
Wang, Y. [4 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Haalthy Inc, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Dept Comprehens Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
real-world study; non-small-cell lung cancer; RET-rearranged;
D O I：
10.1016/j.jtho.2019.08.1786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-01
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [1] Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients
    Zhang, Kai
    Chen, Huajun
    Wang, Ye
    Yang, Lin
    Zhou, Chengzhi
    Yin, Weiqiang
    Wang, Guangsuo
    Mao, Xinru
    Xiang, Jianxing
    Li, Bing
    Zhang, Tengfei
    Fei, Shihong
    ONCOLOGY RESEARCH, 2019, 27 (05) : 575 - 582
  • [2] Clinical Characteristics and Molecular Patterns Of RET-Rearranged Lung Cancer in Chinese Patients
    Fei, S.
    Zhang, K.
    Chen, H.
    Wang, Y.
    Yang, L.
    Zhou, C.
    Yin, W.
    Wang, G.
    Li, B.
    Zhang, T.
    Xiang, J.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1077 - S1077
  • [3] Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice
    Lee, Jiyun
    Ku, Bo Mi
    Shim, Joon Ho
    La Choi, Yoon
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (05) : 594 - 601
  • [4] Identification of Mechanisms of Drug Resistance in RET-Rearranged Lung Cancer
    Nakaoku, T.
    Kohno, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2276 - S2276
  • [5] Identification of mechanisms of drug resistance in RET-rearranged lung cancer
    Nakaoku, Takashi
    Kohno, Takashi
    CANCER SCIENCE, 2018, 109 : 740 - 740
  • [6] Clinical and radiological features of advanced RET-rearranged lung cancer
    Saiki, Masafumi
    Ohyanagi, Fumiyoshi
    Ariyasu, Ryo
    Koyama, Junji
    Sonoda, Tomoaki
    Kawashima, Yosuke
    Takano, Natsuki
    Oguri, Tomoyo
    Nishikawa, Shingo
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ninomiya, Hironori
    Takeuchi, Kengo
    Ishikawa, Yuichi
    Oikado, Katsunori
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
    Drilon, Alexander
    Lin, Jessica J.
    Filleron, Thomas
    Ni, Ai
    Milia, Julie
    Bergagnini, Isabella
    Hatzoglou, Vaios
    Velcheti, Vamsidhar
    Offin, Michael
    Li, Bob
    Carbone, David P.
    Besse, Benjamin
    Mok, Tony
    Awad, Mark M.
    Wolf, Jurgen
    Owen, Dwight
    Camidge, D. Ross
    Riely, Gregory J.
    Peled, Nir
    Kris, Mark G.
    Mazieres, Julien
    Gainor, Justin F.
    Gautschi, Oliver
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : 1595 - 1601
  • [8] Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?
    Drilon, Alexander
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 5 - 6
  • [9] The importance of RET-directed therapy in patients with RET-rearranged non-small cell lung cancer
    Yoh, Kiyotaka
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S121 - S123
  • [10] RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome
    Abbar, Baptiste
    Henry, Carole
    Theou-Anton, Nathalie
    Brosseau, Solenn
    Nguenang, Marina
    Pluvy, Johan
    Assoun, Sandra
    Zalcman, Gerard
    Gounant, Valerie
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : E250 - E251
12345